Predicting the effects of 8C2, a monoclonal anti-topotecan antibody, on plasma and tissue disposition of topotecan-Reference-Cited by-同舟云学术

Predicting the effects of 8C2, a monoclonal anti-topotecan antibody, on plasma and tissue disposition of topotecan

Published:2013-12-25 Issue:1 Volume:41 Page:55-69
ISSN:1567-567X
Container-title:Journal of Pharmacokinetics and Pharmacodynamics
language:en
Short-container-title:J Pharmacokinet Pharmacodyn

Author:

Shah Dhaval K.,Balthasar Joseph P.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s10928-013-9346-9.pdf

Reference36 articles.

1. Balthasar J, Fung HL (1994) Utilization of antidrug antibody fragments for the optimization of intraperitoneal drug therapy: studies using digoxin as a model drug. J Pharmacol Exp Ther 268(2):734–739

2. Balthasar JP, Fung HL (1995) High-affinity rabbit antibodies directed against methotrexate: production, purification, characterization, and pharmacokinetics in the rat. J Pharm Sci 84(1):2–6

3. Balthasar JP, Fung HL (1996) Inverse targeting of peritoneal tumors: selective alteration of the disposition of methotrexate through the use of anti-methotrexate antibodies and antibody fragments. J Pharm Sci 85(10):1035–1043

4. Lobo ED, Balthasar JP (2005) Application of anti-methotrexate Fab fragments for the optimization of intraperitoneal methotrexate therapy in a murine model of peritoneal cancer. J Pharm Sci 94(9):1957–1964

5. Lobo ED, Soda DM, Balthasar JP (2003) Application of pharmacokinetic–pharmacodynamic modeling to predict the kinetic and dynamic effects of anti-methotrexate antibodies in mice. J Pharm Sci 92(8):1665–1676

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of Payload Binding Selectivity Enhancers to Improve Therapeutic Index of Maytansinoid–Antibody–Drug Conjugates;Molecular Cancer Therapeutics;2023-07-25

2. Payload-Binding Fab Fragments Increase the Therapeutic Index of MMAE Antibody–Drug Conjugates;Molecular Cancer Therapeutics;2023-01-31

3. Recent Advances in Translational Pharmacokinetics and Pharmacodynamics Prediction of Therapeutic Antibodies Using Modeling and Simulation;Pharmaceuticals;2022-04-22

4. Bivalent engagement of endothelial surface antigens is critical to prolonged surface targeting and protein delivery in vivo;The FASEB Journal;2020-08

5. Development of a Translational Physiologically Based Pharmacokinetic Model for Antibody-Drug Conjugates: a Case Study with T-DM1;The AAPS Journal;2017-08-14